Πλοήγηση ανά Συγγραφέα "Dardiotis E., Perpati G., Borsos M., Nikolaidis I., Tzanetakos D., Deretzi G., Koutlas E., Kilidireas C., Mitsikostas D.D., Hadjigeorgiou G., Grigoriadis N., Papagiannopoulos S., Orologas A., Aggelidakis P., Antonios A., Fakas N., Papadimitriou A., Iliopoulos I., Kostadima V., Karageorgiou K., Lamprakopoulos S., Nikiforidis D., Voumvourakis K., Kaponi A., Maltezou M., Acquaviva T.P., Kerezoudi E., Balamoutsos G., Kerasnoudis A., Mitsias P., Doskas T., Maris T., Baltogiannis C., Chroni E., The AURELIO investigators"

Αποτελέσματα 1-1 από 1

Real-World Assessment of Quality of Life in Patients with Relapsing Remitting Multiple Sclerosis Treated with Teriflunomide for Two Years: Patient-Reported Outcomes from the AURELIO Study in Greece

Dardiotis E., Perpati G., Borsos M., Nikolaidis I., Tzanetakos D., Deretzi G., Koutlas E., Kilidireas C., Mitsikostas D.D., Hadjigeorgiou G., Grigoriadis N., Papagiannopoulos S., Orologas A., Aggelidakis P., Antonios A., Fakas N., Papadimitriou A., Iliopoulos I., Kostadima V., Karageorgiou K., Lamprakopoulos S., Nikiforidis D., Voumvourakis K., Kaponi A., Maltezou M., Acquaviva T.P., Kerezoudi E., Balamoutsos G., Kerasnoudis A., Mitsias P., Doskas T., Maris T., Baltogiannis C., Chroni E., The AURELIO investigators (2022)

Introduction: Multiple sclerosis (MS) is a highly heterogeneous inflammatory disease of the central nervous system. Patient-reported outcomes (PROs) in a real-world clinical setting can provide detailed information about ...